Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ENSG · against 1,216 other Healthcare companies
Ranked #360 of 1,217 · scores higher than 70% of peers
Bars: peers in each 10-point band of the growth score121 peers with a growth score of 70–79, including ENSG · Click a bar to see the companies
Mainly thanks to its 3-year revenue growth and revenue growth, which are stronger than most Healthcare peers.
| Metric | ENSG | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | 18.9% | 6.1% | 77% | 33% | |
| Earnings per share growthHigher is better · 682 reported | 16.1% | 9.7% | 58% | 33% | |
| 3-year revenue growthHigher is better · 1,192 reported | 17.4% | 5.8% | 77% | 33% |
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 360 | 73.2B SAR (≈$19.8B) | 70 | 56 | |
| 360 | 7.2B CNY (≈$1.0B) | 70 | 74 | |
| 360 | 1.21T INR (≈$14.6B) | 70 | 55 | |
| 360 | 635M USD | 70 | 39 | |
| 360 | 10.6B USD | 70 | 64 | |
| 360 | 596.9B INR (≈$7.2B) | 70 | 58 | |
| 360 | 494.7B INR (≈$5.9B) | 70 | 70 | |
| 360 | 63M EUR (≈$70M) | 70 | 46 | |
| 360 | 595M USD | 70 | 29 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score